Meryem K. Talbo


The following work is half metaphorical ink and half real caffeine

(more commonly known: published work)

  1. Cheveldayoff P, Chowdhury F, Shah N, Burow C, Figueiredo M, Nguyen N, Talbo MK, Jamasi R, Katz A, Pasquale C and Hill L. Considerations for occupational heat exposure: A scoping review. PLOS Climate 2(9): e0000202
  2. Hill L, Roofigari N, Faraz M, Popov J, Moshkovich M, Figueiredo M, Hartung E, Talbo MK, Lalanne-Mistrih ML, Sherlock M, Zachos M, Timmons BW, Obeid J, Pai N. Physical Activity in Pediatric Inflammatory Bowel Disease: A Scoping Review. Pediatr Exerc Sci. 2023 Jul 24:1-13. doi: 10.1123/pes.2022-0078. Epub ahead of print. PMID: 37487582.
  3. Katz A, Shulkin A, Talbo MK, Housni A, Yardley J, Brazeau AS, Rabasa-Lhoret R. Hyperglycemia-related anxiety during competition in an elite athlete with type 1 diabetes: a case report. Diabetes Metab. 2023 Sep;49(5):101476. doi: 10.1016/j.diabet.2023.101476.
  4. Talbo MK, Katz A, Hill L, Peters TM, Yale JF, Brazeau AS. Effect of diabetes technologies on the fear of hypoglycaemia among people living with type 1 diabetes: a systematic review and meta-analysis. EClinicalMedicine. 2023;62:102119. Published 2023 Aug 4. doi:10.1016/j.eclinm.2023.102119
  5. Talbo MK, Lebbar M, Wu Z, Vanasse A, Lalanne-Mistrih ML, Brazeau AS, Rabasa-Lhoret R. Gender differences in reported frequency and consequences of hypoglycemia among adults living with type 1 diabetes: Results from the BETTER registry. Diabetes Res Clin Pract. 2023;202:110822. doi:10.1016/j.diabres.2023.110822
  6. Talbo MK, Rabasa-Lhoret R, Yale JF, Peters T, Brazeau AS. Are nocturnal hypoglycemia prevention strategies influenced by diabetes technology usage? A BETTER registry analysis. Diabetes Research and Clinical Practice, September 2022.
  7. Talbo MK, Katz A, Dostie M, Legault L, Brazeau AS. Associations Between Socioeconomic Status and Patient Experience With Type 1 Diabetes Management and Complications: Cross-sectional Analysis of a Cohort From Québec, Canada. Can J Diabetes. 2022 Aug;46(6):569-577.
  8. Talbo MK, Peters T, Brazeau AS, Yale JF, Rabasa-Lhoret R. Can continuous glucose monitoring technology reduce fear of hypoglycemia in people with type 1 diabetes? Pol Arch Intern Med. 2022; 132(2): 16209. doi:10.20452/pamw.16209 (Letter to the editor)
  9. Katz A, Talbo MK, Xie LF, Nakhla MM, Brazeau AS. Media Portrayal of Type 1 Diabetes in North American Television and Film. Canadian Journal of Diabetes, 2022; in press.
  10. Prevost M, Rabasa-Lhoret R, Talbo MK, Yardley J, Curry E, Brazeau AS. Gender Differences in Strategies to Prevent Physical Activity–Related Hypoglycemia in Patients with Type 1 Diabetes: A BETTER Study. Diabetes Care. 2022
  11. Brazeau AS, Messier V, Talbo MK, Gagnon C, Taleb N, Fortier I, Wu Z, Perkins B, Carpentier AC, Bandini A, Rabasa-Lhoret R on behalf of the BETTER study group. Type 1 Diabetes Population Surveillance Through the BETTER Patient-Engagement Registry: Development and Baseline Characteristics. Canadian Journal of Diabetes. 2022
  12. Talbo MK, Besner ME, Plourde H, Claveau M, Beltempo M. Association of Caloric Intake, Protein Intake, and Enteral Feeding Initiation with Weight Gain in Infants Born 32 to 34 Weeks’ Gestation. American Journal of Perinatology. 2019